Diamyd Medical AB (OSTO:DMYD B) Net Issuance of Preferred Stock : kr0.00 Mil (TTM As of May. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Diamyd Medical AB's net issuance of preferred for the three months ended in May. 2025 was kr0.00 Mil. The number is 0, which means that Diamyd Medical AB has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Diamyd Medical AB's net issuance of preferred for the trailing twelve months (TTM) ended in May. 2025 was kr0.00 Mil.

Diamyd Medical AB Net Issuance of Preferred Stock Historical Data

The historical data trend for Diamyd Medical AB's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Net Issuance of Preferred Stock Chart

Diamyd Medical AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Diamyd Medical AB Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Diamyd Medical AB Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Diamyd Medical AB Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

DYMDF:USA

Address

Kungsgatan 29, Stockholm, SWE, SE-111 56

Website

https://www.diamyd.com

Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines